A consortium to begin the development of the next COVID-19 vaccine is underway at The Infections Disease Research Institute (IDRI). The Washington-based non-profit is working to ensure the next generation of the vaccine can withstand more moderate temperatures and improve immunity for longer periods of time without additional booster shots.
“The first-generation vaccines were incredibly important, but they are not sufficient to take us through this pandemic or for the next pandemic,” said IDRI CEO Corey Casper, M.D., MPH.